Test Price
900 AEDโ Home Collection Available
Respiratory Syncytial Virus (RSV) A & B RNA Detection, Qualitative Test in UAE | 900 AED
Executive Summary & Core Metrics
Executive Summary
The RSV A & B RNA Detection Qualitative Test delivers 99.9% diagnostic sensitivity through ISO 9001:2015 accredited processing. The service includes hospital-grade home collection via cold-chain logistics, telephonic post-test clinical guidance, and direct insurance billing verification. Price: 900 AED, result within 36 hours via phone.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The RSV A&B RNA Detection Qualitative Test uses Real-Time PCR (qPCR) to identify the genetic material of Respiratory Syncytial Virus subtypes A and B from respiratory specimens, providing highly sensitive and specific acute infection diagnosis. This molecular assay offers superior performance compared to rapid antigen tests.
| Feature | Our RSV RNA PCR Test | Rapid Antigen Test |
|---|---|---|
| Methodology | Real-Time PCR (qPCR) + Whole Genome Sequencing | Lateral Flow Immunoassay |
| Clinical Sensitivity | >99.9% | 50โ70% |
| Turnaround Time | 36 hours (phone) / 48 hours (email) | 15โ30 minutes |
| Specimen Types | Nasopharyngeal swab, sputum, bronchial lavage, lung tissue | Nasal swab only |
| Regulatory Compliance | DHA/MOHAP, ISO 9001:2015, Federal Decree-Law No. 45 of 2021 | Point-of-care use only |
Physician Insight & Safety Protocols
As a DHA-licensed General Practitioner, I emphasize that PCR-based RSV RNA detection is the gold standard for confirming acute infection, especially in high-risk infants, elderly, and immunocompromised patients. A positive result should guide isolation and supportive care, while a negative result in a symptomatic patient warrants consideration of other respiratory pathogens. Always correlate with clinical presentation and never rely on a single test for clinical decisions. โ Dr. Ajay Singh, DHA License: 36234132
Advisory Note
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This test does not replace clinical evaluation.
Exclusion Criteria & ER Red Flags
- Inability to provide informed consent (minors require legal guardian per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Severe coagulopathy, recent nasal surgery, or uncontrolled epistaxis.
- Acute severe respiratory distress, cyanosis, or high fever unresponsive to antipyretics.
If you experience any of the above, seek emergency care immediately. This test is not a substitute for urgent medical attention.
Patient FAQ & Clinical Guidance
1. What is the difference between RSV A and RSV B, and why test for both?
The qualitative RNA test differentiates RSV A and B subtypes because they cause similar symptoms but differ in epidemic patterns and severity, essential for targeted patient management. Both subtypes can cause severe lower respiratory tract infection in infants and the elderly; identifying the circulating subtype supports outbreak surveillance and hospital resource planning.
2. When should I get tested for RSV, and what specimen is needed?
Testing is recommended when acute respiratory symptoms such as cough, wheezing, and fever appear, especially during NovemberโApril peak season in the UAE. A nasopharyngeal swab collected by our mobile phlebotomy team in viral transport medium is the standard specimen; sputum or bronchial lavage may be used for hospitalized patients. Fasting is not required for this PCR assay.
3. How accurate is this test, and when will I receive results?
Our Real-Time PCR assay achieves 99.9% diagnostic sensitivity and 100% specificity for RSV RNA, outperforming antigen-based methods by detecting virus early in infection. Results are delivered by phone within 36 hours and via secure email within 48 hours; integration with WGS enables advanced molecular surveillance. You will also receive a telephonic interpretation by our clinical team to discuss next steps.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
This test is performed in compliance with Dubai Health Authority (DHA) standards and UAE federal laws. All patient data is processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and safety protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your data is encrypted, stored securely, and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | Respiratory Syncytial Virus (RSV) A & B RNA Detection, Qualitative Test |
| Price (AED) | 900 |
| Turnaround Time | 36 hours (phone) / 48 hours (email) |
| Sample Type / Matrix | Nasopharyngeal swab, sputum, bronchial lavage, lung tissue |
| Methodology Used | Real-Time PCR (qPCR) with Whole Genome Sequencing |
| ICD-10-CM Code | J12.1, J20.5, J21.0 |
| LOINC Code | 58762-9 |
| DHA Facility License & Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians